Glox Therapeutics

Glox Therapeutics develops precision antibiotics based on engineered bacteriocins, targeting specific drug-resistant bacteria with high efficacy and minimal impact on the human microbiome. Their novel approach addresses the growing threat of antimicrobial resistance, offering a more effective and safer treatment strategy. The company is built upon over 20 years of research at the Universities of Glasgow and Oxford.

+ 0 Upvotes
Buy Funded Startups lists